Funding Details
- Date Award
- May 13, 2024
- Vertical
- Diagnostics
- Funding URL
- View Funding Page
Company Info
- Founders
- Mridu Sinha
- Company Description
- Melio is breaking the one-pathogen one-probe paradigm in diagnostics to deliver the unmet holy grail for pathogen testing for bloodstream infections. Melio delivers diagnostic capabilities that are scalable “over the air” with a few universal probes, without making any changes to hardware. Melio is disrupting the century-old paradigm of slow and inefficient pathogen testing. First, we are bringing our product to the vulnerable newborn population, where, for the lack of better diagnostics, 150 babies are given antibiotics for every 1 that truly needs it.
- Market
- Human Health
- Location
-
US
Links